Handelsbanken Fonder’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-13,051
| Closed | -$149K | – | 1773 |
|
|
2021
Q3 | $149K | Hold |
13,051
| – | – | ﹤0.01% | 1665 |
|
|
2021
Q2 | $209K | Buy |
+13,051
| New | +$209K | ﹤0.01% | 1690 |
|
|
2020
Q3 | – | Sell |
-440,551
| Closed | -$6.5M | – | 1477 |
|
|
2020
Q2 | $6.5M | Sell |
440,551
-62,449
| -12% | -$922K | 0.05% | 282 |
|
|
2020
Q1 | $6.79M | Buy |
503,000
+130,000
| +35% | +$1.75M | 0.15% | 134 |
|
|
2019
Q4 | $9.02M | Buy |
373,000
+65,000
| +21% | +$1.57M | 0.16% | 134 |
|
|
2019
Q3 | $5.92M | Sell |
308,000
-77,800
| -20% | -$1.5M | 0.12% | 141 |
|
|
2019
Q2 | $11.4M | Sell |
385,800
-10,000
| -3% | -$295K | 0.21% | 122 |
|
|
2019
Q1 | $18.8M | Buy |
395,800
+2,500
| +0.6% | +$119K | 0.36% | 72 |
|
|
2018
Q4 | $14.2M | Buy |
393,300
+63,300
| +19% | +$2.29M | 0.29% | 97 |
|
|
2018
Q3 | $20.3M | Buy |
330,000
+25,000
| +8% | +$1.54M | 0.38% | 82 |
|
|
2018
Q2 | $20.6M | Buy |
305,000
+45,000
| +17% | +$3.04M | 0.4% | 78 |
|
|
2018
Q1 | $14.1M | Buy |
260,000
+130,000
| +100% | +$7.05M | 0.28% | 97 |
|
|
2017
Q4 | $7.77M | Hold |
130,000
| – | – | 0.17% | 111 |
|
|
2017
Q3 | $6.32M | Hold |
130,000
| – | – | 0.15% | 127 |
|
|
2017
Q2 | $6.83M | Buy |
130,000
+57,000
| +78% | +$3M | 0.17% | 112 |
|
|
2017
Q1 | $3.31M | Buy |
+73,000
| New | +$3.31M | 0.09% | 133 |
|
|
2016
Q1 | – | Sell |
-45,000
| Closed | -$1.1M | – | 622 |
|
|
2015
Q4 | $1.1M | Buy |
+45,000
| New | +$1.1M | 0.02% | 476 |
|